Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Folia Medica Indonesiana Indonesian Health Journal
Meuthia, Feranti
Unknown Affiliation
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary Other

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Coronary Artery Disease in Patient with An Anomalous Origin of Right Coronary Artery D. Nugraheni, Winda; Meuthia, Feranti
Indonesian Health Journal (IHJ) Vol. 3 No. 2 (2024): Indonesian Health Journal
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/ihj.v3i2.411

Abstract

Coronary artery disease (CAD) remains a leading cause of mortality and morbidity in developed countries. CAD is a pathological process characterized by the accumulation of atherosclerotic plaques in the epicardial arteries, both obstructive and non-obstructive. This study aims to investigate rare cases of anomalous right coronary artery arising from the left main coronary artery and its clinical implications for coronary artery disease (CAD). The research methodology involved clinical examinations, echocardiography, diagnostic coronary angiography, and computed tomography angiography (CCTA) to obtain a comprehensive understanding of this case. The research findings indicate severe stenosis in the proximal-mid left main coronary artery (LAD) and an anomalous origin of the right coronary artery (RCA) leading to lower-level stenosis. Percutaneous coronary intervention (PCI) on the proximal-mid LAD lesion resulted in significant improvement in the patient's condition. The implications of this research underscore the importance of a deep understanding of coronary artery anatomical variations for accurate diagnosis and appropriate management of CAD patients, especially in rare cases like this.  
Thrombocytopenia in a Patient Undergoing Primary Percutaneous Coronary Intervention Oktaviono, Yudi Her; Meuthia, Feranti
Folia Medica Indonesiana Vol. 55 No. 1 (2019): March
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (225.434 KB) | DOI: 10.20473/fmi.v55i1.24434

Abstract

Thrombocytopenia is a common abnormality in patients presenting with acute coronary syndrome. Baseline thrombocytopenia in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention is associated with early adverse events, related to both ischemia and bleeding. Treatment for acute coronary syndrome usually involves antiplatelet, anticoagulant, antithrombotic therapy, and the performance of percutaneous coronary intervention. The safety of antiplatelet therapy and percutaneous coronary intervention patients who have acute coronary syndrome and thrombocytopenia is unknown, and there are no guidelines or randomized studies that specifically suggest a treatment approach in such patients. One of the institutions in Italy recommends medical and interventional strategy with radialis as first choice for access site, bare metal stent (BMS) implantation, followed by double antiplatelet therapy (DAPT) for one month. After DAPT discontinuation, at least one antiplatelet drug (aspirin) is recommended for life.
Co-Authors D. Nugraheni, Winda Yudi Her Oktaviono, Yudi Her